Respicardia amasses $58.5 mln

Minnesota-based Respicardia, Inc, a medical technology company focused on improving heart health, has raised $58.5 million in financing. ZOLL Medical Corporation was the lead investor.

19 December 2017•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail